Abstract

Increasing evidence supports the role of brain and systemic inflammation in the etiology of Parkinson disease (PD). We used gene expression profiling to examine the activation state of peripheral blood monocytes in 18 patients with early, untreated PD and 16 healthy control (HC) subjects. Monocytes were isolated by negative selection, and gene expression studied by RNA-seq and gene set enrichment analysis. A computational model that incorporated case/control status, sex, and the interaction between case/control status and sex was utilized. We found that there was a striking effect of sex on monocyte gene expression. There was inflammatory activation of monocytes in females with PD, with enrichment of gene sets associated with interferon gamma stimulation. In males, the activation patterns were more heterogeneous. These data point to the importance of systemic monocyte activation in PD, and the importance of studies which examine the differential effects of sex on pathophysiology of the disease.

Details

Title
Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease
Author
Carlisle, Samantha M 1   VIAFID ORCID Logo  ; Qin Hongwei 2 ; Curtis, Hendrickson R 3   VIAFID ORCID Logo  ; Muwanguzi, Jordana E 4 ; Lefkowitz, Elliot J 4   VIAFID ORCID Logo  ; Kennedy, Richard E 5 ; Zhaoqi, Yan 2 ; Yacoubian Talene A 6 ; Benveniste, Etty N 2 ; West, Andrew B 7   VIAFID ORCID Logo  ; Harms, Ashley S 6   VIAFID ORCID Logo  ; Standaert, David G 6   VIAFID ORCID Logo 

 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); University of Alabama at Birmingham, Center for Clinical and Translational Science, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); New Mexico State University, Department of Chemistry and Biochemistry, Las Cruces, USA (GRID:grid.24805.3b) (ISNI:0000 0001 0687 2182) 
 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); University of Alabama at Birmingham, Department of Cell, Developmental and Integrative Biology, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187) 
 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); University of Alabama at Birmingham, Center for Clinical and Translational Science, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187) 
 University of Alabama at Birmingham, Center for Clinical and Translational Science, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187) 
 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187) 
 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); University of Alabama at Birmingham, Department of Neurology, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187) 
 University of Alabama at Birmingham, Alabama Morris K. Udall Center of Excellence in Parkinson’s Disease Research, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187); Duke University, Department of Pharmacology & Cancer Biology, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
23738057
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2512157977
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.